Backman, Janne T <br/><br/>
CYP2C8 activity recovers within 96 hours after gemfibrozil dosing: estimation of CYP2C8 half-life using repaglinide as an in vivo probe.  [electronic resource] 

 -  Drug metabolism and disposition: the biological fate of chemicals  Dec 2009 
 - 2359-66 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1521-009X 
<br/><br/><label>Standard No.: </label>10.1124/dmd.109.029728  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Area Under Curve<br/>Aryl Hydrocarbon Hydroxylases--antagonists & inhibitors<br/>Biotransformation<br/>Blood Glucose--drug effects<br/>Carbamates--administration & dosage<br/>Cross-Over Studies<br/>Cytochrome P-450 CYP2C8<br/>Drug Interactions<br/>Enzyme Inhibitors--administration & dosage<br/>Female<br/>Gemfibrozil--administration & dosage<br/>Genotype<br/>Glucuronates--blood<br/>Half-Life<br/>Humans<br/>Hypoglycemic Agents--administration & dosage<br/>Hypolipidemic Agents--administration & dosage<br/>Liver-Specific Organic Anion Transporter 1<br/>Male<br/>Models, Biological<br/>Molecular Probes--administration & dosage<br/>Organic Anion Transporters--genetics<br/>Phenotype<br/>Piperidines--administration & dosage<br/>Young Adult